Related Experiment Video

Updated: Nov 14, 2025

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.2K

Combination Therapies for Precision Oncology: The Ultimate Whack-A-Mole Game

Roman Groisberg1, Vivek Subbiah2,3,4

  • 1Department of Melanoma/Sarcoma Medical Oncology and Phase 1, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|March 12, 2021
PubMed

Insights

Combining trametinib with palbociclib shows promise for cancer patients with specific pathway aberrations. This dual-targeted therapy is safe, well-tolerated, and effective across various tumor types.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Single-agent MEK inhibitors (MAPK pathway) and CDK4/6 inhibitors (cyclin pathway) show limited efficacy in tumors with aberrant signaling.
  • Tumors often harbor co-occurring aberrations in multiple oncogenic pathways, necessitating combination therapies.

Purpose of the Study:

  • To evaluate the safety, tolerability, and clinical activity of combining trametinib (a MEK inhibitor) with palbociclib (a CDK4/6 inhibitor).
  • To determine if this combination therapy is effective in a histology-independent manner for patients with co-occurring pathway aberrations.

Main Methods:

  • Phase I/II clinical trial design.
  • Administration of trametinib and palbociclib in combination.
  • Assessment of adverse events for safety and tolerability.
  • Evaluation of tumor response and clinical benefit for efficacy.

Main Results:

  • The combination of trametinib and palbociclib was found to be safe and well-tolerated.
  • Clinical activity was observed in patients with tumors harboring co-occurring MAPK and cyclin pathway aberrations.
  • Efficacy was demonstrated in a histology-independent manner, suggesting broad applicability.

Conclusions:

  • The combination of trametinib and palbociclib represents a viable therapeutic strategy for patients with tumors exhibiting co-occurring pathway aberrations.
  • This combination approach offers a promising new treatment option, overcoming the limitations of single-agent therapies.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.1K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
826
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
617